CNSL vs. CEL, FOX, OTT, BCE, CZN, CHT, DVW, BRCI, NPT, and RCI
Should you be buying Cambridge Nutritional Sciences stock or one of its competitors? The main competitors of Cambridge Nutritional Sciences include Celadon Pharmaceuticals (CEL), Fox Marble (FOX), Oxford Technology 3 Venture Capital Trust (OTT), Beacon Energy (BCE), Curzon Energy (CZN), 290005 (CHT.L) (CHT), 5008 (DVW.L) (DVW), BlackRock Comms Income Inv Tst (BRCI), NetPlay TV (NPT), and RapidCloud International (RCI). These companies are all part of the "communication" industry.
Cambridge Nutritional Sciences vs.
Celadon Pharmaceuticals (LON:CEL) and Cambridge Nutritional Sciences (LON:CNSL) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their valuation, risk, analyst recommendations, earnings, dividends, media sentiment, community ranking, profitability and institutional ownership.
10.7% of Celadon Pharmaceuticals shares are held by institutional investors. Comparatively, 10.2% of Cambridge Nutritional Sciences shares are held by institutional investors. 65.1% of Celadon Pharmaceuticals shares are held by insiders. Comparatively, 10.9% of Cambridge Nutritional Sciences shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.
Celadon Pharmaceuticals has a beta of -0.26, indicating that its share price is 126% less volatile than the S&P 500. Comparatively, Cambridge Nutritional Sciences has a beta of 3.89, indicating that its share price is 289% more volatile than the S&P 500.
Cambridge Nutritional Sciences has a net margin of -3.36% compared to Celadon Pharmaceuticals' net margin of -4,024.62%. Cambridge Nutritional Sciences' return on equity of -3.34% beat Celadon Pharmaceuticals' return on equity.
Celadon Pharmaceuticals received 4 more outperform votes than Cambridge Nutritional Sciences when rated by MarketBeat users.
Cambridge Nutritional Sciences has higher revenue and earnings than Celadon Pharmaceuticals.
In the previous week, Celadon Pharmaceuticals had 1 more articles in the media than Cambridge Nutritional Sciences. MarketBeat recorded 1 mentions for Celadon Pharmaceuticals and 0 mentions for Cambridge Nutritional Sciences. Celadon Pharmaceuticals' average media sentiment score of 1.84 beat Cambridge Nutritional Sciences' score of 0.00 indicating that Celadon Pharmaceuticals is being referred to more favorably in the media.
Summary
Celadon Pharmaceuticals beats Cambridge Nutritional Sciences on 7 of the 13 factors compared between the two stocks.
Get Cambridge Nutritional Sciences News Delivered to You Automatically
Sign up to receive the latest news and ratings for CNSL and its competitors with MarketBeat's FREE daily newsletter.
Media Sentiment Over Time
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Cambridge Nutritional Sciences Competitors List
Related Companies and Tools
This page (LON:CNSL) was last updated on 3/3/2025 by MarketBeat.com Staff
Free CNSL Stock Alerts